Sarepta Therapeutics, Inc. SRPT Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s free cash flow yield?
- Sarepta Therapeutics, Inc. (SRPT) reported free cash flow yield of -4% in Q3 2024.
- How has Sarepta Therapeutics, Inc.'s free cash flow yield changed year-over-year?
- Sarepta Therapeutics, Inc.'s free cash flow yield increased by 29.0% year-over-year, from -5.6% to -4%.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s free cash flow yield?
- Over 2 years (2021 to 2023), Sarepta Therapeutics, Inc.'s free cash flow yield has grown at a 2.1% compound annual growth rate (CAGR), from -6.1% to -6.4%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.